MYC and LYN are coexpressed and have interdependent clinical outcomes.

Slides:

Advertisements

Similar presentations

Triple-Negative Breast Cancer

Advertisements

Rate of breast cancer-specific survival Months Low gene expression (N=252) High gene expression (N=37) P < (Log-rank) a Months Low gene expression.

A B C Supplementary Figure S1. Time-dependent assessment of grade, GGI and PAM50 in untreated patients Landmark analyses of the Kaplan-Meier estimates.

Breast Cancer Risk in Usual Ductal Hyperplasia Is Defined by Estrogen Receptor-α and Ki-67 Expression Abeer M. Shaaban, John P. Sloane, Christopher R.

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype. Radiologic assessment in triple-negative breast cancer (A), HER2-positive.

Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive.

Hallett, et al., - Supplementary Figure 1

Figure S1. DCYTB expression is higher in ER+ than ER- patients

سرطان الثدي Breast Cancer

CD25 expression is associated with unfavorable clinical outcome.

The immune metagene model has prognostic value in IBE but not in IBD breast cancer. The immune metagene model has prognostic value in IBE but not in IBD.

Frequency of JAK1 and JAK2 alterations and their association with overall survival in TCGA datasets. Frequency of JAK1 and JAK2 alterations and their association.

Fig. 2 LYM attractor metagene.

Prognostic significance of DDB2 in ovarian cancer.

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Kaplan–Meier curves for a, b) progression-free survival (PFS) and c, d) overall survival (OS) in a, c) large-cell neuroendocrine carcinoma patients and.

Intrinsic and acquired trastuzumab resistance.

Kaplan–Meier curves of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) progression-free survival (PFS) were constructed based on.

Tumor intrinsic subtype is reflected in cancer-adjacent tissue.

Treatment of human MCC tumors with intralesional IFNβ is associated with MHC-I upregulation. Treatment of human MCC tumors with intralesional IFNβ is associated.

Tumoral presence of human cytomegalovirus is associated with shorter disease-free survival in elderly patients with colorectal cancer and higher levels.

B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.

Distribution of intrinsic subtypes among TNBC and distribution of TNBC among basal-like breast cancer. Distribution of intrinsic subtypes among TNBC and.

Triple‐negative human breast cancers specifically express high levels of nuclear HMGA2, whose expression has clinical relevance and predicts recurrence‐free.

ADAM8 is overexpressed in human breast cancer AADAM8 mRNA expression in samples from breast tumor and normal breast tissue was analyzed using the Oncomine.

LATS2-associated gene expression pattern is down-regulated specifically in lumB breast tumors. LATS2-associated gene expression pattern is down-regulated.

(A) Distribution of LATS2 mRNA expression levels in different breast cancer subtypes (PAM50, METABTIC dataset); ***P-value < 0.001, t test comparing lumB.

Kaplan–Meier curves of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) progression-free survival (PFS) for EGFR mutant lung adenocarcinoma.

Fig. 2 LYM attractor metagene.

MiR-520d-3p is an independent positive prognostic factor in ovarian cancer. miR-520d-3p is an independent positive prognostic factor in ovarian cancer.

Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.

Progastrin expression in colonic tissues and Kaplan–Meier survival curves. Progastrin expression in colonic tissues and Kaplan–Meier survival curves. A,

Landscape of the TME in gastric cancer and characteristics of TME subtypes. Landscape of the TME in gastric cancer and characteristics of TME subtypes.

CXCL14-positive CAFs induce overexpression of LINC00092 in ovarian cancer. CXCL14-positive CAFs induce overexpression of LINC00092 in ovarian cancer. A,

Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,

Immune signatures of patients with short-, medium-, and long-term survival. Immune signatures of patients with short-, medium-, and long-term survival.

CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated with a longer survival. CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated.

IL-13Rα2 expression is associated to human colon cancer progression and poor survival of patients with colorectal cancer. IL-13Rα2 expression is associated.

Tamoxifen-treated patients.

Personalized, 16-plex assays accurately detect ctDNA ahead of clinical relapse. Personalized, 16-plex assays accurately detect ctDNA ahead of clinical.

EN1 expression in breast cancer and clinical outcome.

Somatic mutational rates and survival analysis of IBD-CRC.

ALDH1A3 expression levels are inversely correlated with the survival of patients with resectable mass-forming and advanced cholangiocarcinoma, respectively.

ORs estimates for ER breast cancer subtypes in postmenopausal women ccording to tertiles of sex steroid hormone and SHBG levels. ORs estimates for ER breast.

Mir-128 reduction in breast cancer tissues correlates chemotherapy resistance and poor patient survival. Mir-128 reduction in breast cancer tissues correlates.

Survival risk prediction analysis and application of the metastasis gene signature. Survival risk prediction analysis and application of the metastasis.

Reduced klotho expression in pancreatic cancer.

Clustering analysis of DTC-associated genes.

MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients treated with tamoxifen. MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients.

Influence of ASGR2 expression on survival.

Kaplan–Meier curves for RFS and OS by various marker groups.

Expression of HO-1 by the FAP+/F4/80+ tumoral macrophages.

Association of overall survival and PAP-specific (A, B) and PA2024-specific (C, D) CTL activity at week 26 using categorical (tertile) analysis and continuous.

Expression of 20 genes significantly associated with reduced survivability in GBM is shown across 33 TCGA diseases. Expression of 20 genes significantly.

Frequently mutated genes in colorectal cancer.

Patient stratification using survival risk prediction and BCLC staging

MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.

Validation of MYC-driven drug responses.

Expression of chemokine receptors in A-498 cell line.

Global analysis of the chemical–genetic interaction map.

Expression of TGFβ ligands in GBM

Immunohistochemical determination of TIM-3 expression in ccRCC.

CD36 expression is coordinately regulated in multiple cellular compartments. CD36 expression is coordinately regulated in multiple cellular compartments.

Transcriptome traits and clinical characteristics of TME phenotypes in the ACRG cohort. Transcriptome traits and clinical characteristics of TME phenotypes.

TME characteristics of TCGA-STAD subtype and cancer somatic genome.

Construction of TME signatures and functional annotation.

Kaplan–Meier curves of relapse-free survival of the CAR-T cohort (left) and the HCT cohort (right) of 8 CAR-T patients and 12 HCT patients whose preceding.

GSN and DNMT1 expression are inversely correlated in a pattern associated with patient survival. GSN and DNMT1 expression are inversely correlated in a.

Kaplan-Meier (K-M) curves of progression-free survival (PFS) in 54 patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier (K-M) curves.

Presentation transcript:

MYC and LYN are coexpressed and have interdependent clinical outcomes. MYC and LYN are coexpressed and have interdependent clinical outcomes. A, coexpression of MYC and LYN across 789 cancer cell lines, data from ref. 2. Groups of cell lines are binned by MYC expression. Expression of MYC and LYN across patients in the breast TCGA (23) separated on the basis of patient PAM50 subtype (B) and the number of positively stained molecular receptors (ER, PR, or HER2; C). Whiskers span the 10th to 90th percentiles. All expression values are relative units. D and E, the Kaplan–Meier relapse-free survival (RFS) curves of I-SPY 1 patients stratified by LYN expression levels (D) patient subset with highest tertile of MYC expression levels (n = 50). E, patient subset with lowest tertile of MYC expression levels (n = 99). Maria M. Martins et al. Cancer Discov 2015;5:154-167 ©2015 by American Association for Cancer Research